Skip to main content
Top
Published in: Infection 6/2017

01-12-2017 | Original Paper

Pathogen or contaminant? Distinguishing true infection from synovial fluid culture contamination in patients with suspected septic arthritis

Authors: Mary Louise Fowler, Clara Zhu, Kevin Byrne, Sarah B. Lieber, Andrew Moore, Robert H. Shmerling, Ziv Paz

Published in: Infection | Issue 6/2017

Login to get access

Abstract

Background

Isolation of bacteria from synovial fluid (SF) is the gold standard for diagnosis of septic arthritis (SA). Contamination results in misdiagnosis and mismanagement. This study identifies clinical characteristics, microbiology, and outcomes of patients with contaminated SF and compares them with patients with true SA.

Methods

We conducted a retrospective study including all patients aged 18 and older admitted to a single, tertiary-care hospital between 1998 and 2015 with suspected SA and positive SF cultures. Contamination cases were determined by infectious disease specialists involved in the patients’ care and a clinical course inconsistent with SA.

Results

398 patients with true SA and 22 with contaminated SF were identified. The SA group was younger (60.9 vs. 75.6 years; p < 0.01), had higher peripheral polymorphonuclear lymphocytes (78.0 vs. 69.4%; p < 0.01) and SF white blood cell count (91.7 vs. 25.6K/mL; p = 0.02), and longer mean length of stay (10.9 vs. 6.7 days; p = 0.02). The average time to positive culture was longer in the contaminated group (3.62 vs. 1.4 days; p < 0.01). The SA group was less likely to receive a new rheumatologic diagnosis within 1 year (3.0 vs. 36.4%; p < 0.01).

Conclusion

This is the first study of its kind looking at clinical features and outcomes of patients with contaminated SF. These patients present with less severe disease, have better outcomes, and receive new rheumatologic diagnoses in more than a third of cases within 1 year. We recommend a conservative approach for patients with suspected contaminated SF, mild symptoms, and no bacterial growth within the first 48 h.
Literature
1.
go back to reference Souvenir D, Andersion DE Jr, Palpant S, et al. Blood cultures positive for coagulase-negative staphylococci: antisepsis, pseudobacteremia, and therapy of patients. J Clin Microbiol. 1998;36:1923–6.PubMedPubMedCentral Souvenir D, Andersion DE Jr, Palpant S, et al. Blood cultures positive for coagulase-negative staphylococci: antisepsis, pseudobacteremia, and therapy of patients. J Clin Microbiol. 1998;36:1923–6.PubMedPubMedCentral
2.
go back to reference Bates DW, Goldman L, Lee TH. Contaminant blood cultures and resource utilization. JAMA. 1991;265:365–9.CrossRefPubMed Bates DW, Goldman L, Lee TH. Contaminant blood cultures and resource utilization. JAMA. 1991;265:365–9.CrossRefPubMed
3.
go back to reference Bates DW, Cook EF, Goldman L, Lee TH. A prospectively validated model for predicting bacteremia in hospitalized patients. Ann Intern Med. 1990;113:495–500.CrossRefPubMed Bates DW, Cook EF, Goldman L, Lee TH. A prospectively validated model for predicting bacteremia in hospitalized patients. Ann Intern Med. 1990;113:495–500.CrossRefPubMed
4.
go back to reference Weinstein MP, Towns ML, Quartey SM, et al. The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin Infect Dis. 1997;24:584–602.CrossRefPubMed Weinstein MP, Towns ML, Quartey SM, et al. The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin Infect Dis. 1997;24:584–602.CrossRefPubMed
5.
go back to reference Richter SS, Beekmann SE, Croco JL, et al. Minimizing the workup of blood culture contaminants: implementation and evaluation of a laboratory-based algorithm. J Clin Microbiol. 2002;40:2437–44.CrossRefPubMedPubMedCentral Richter SS, Beekmann SE, Croco JL, et al. Minimizing the workup of blood culture contaminants: implementation and evaluation of a laboratory-based algorithm. J Clin Microbiol. 2002;40:2437–44.CrossRefPubMedPubMedCentral
6.
7.
go back to reference Tashiro M, Izumikawa K, Ashizawa N, Narukawa M, Yamamoto Y. Clinical significance of methicillin-resistant coagulase-negative staphylococci obtained from sterile specimens. Diagn Microbiol Infect Dis. 2015;81:71–5.CrossRefPubMed Tashiro M, Izumikawa K, Ashizawa N, Narukawa M, Yamamoto Y. Clinical significance of methicillin-resistant coagulase-negative staphylococci obtained from sterile specimens. Diagn Microbiol Infect Dis. 2015;81:71–5.CrossRefPubMed
8.
go back to reference Weinstein MP. Current blood culture methods and systems: clinical concepts, technology, and interpretation of results. Clin Infect Dis. 1996;23:40–6.CrossRefPubMed Weinstein MP. Current blood culture methods and systems: clinical concepts, technology, and interpretation of results. Clin Infect Dis. 1996;23:40–6.CrossRefPubMed
9.
go back to reference Strand CL, Wajsbort RR, Sturmann K. Effect of iodophor vs iodine tincture skin preparation on blood culture contamination rate. JAMA. 1993;269:1004–6.CrossRefPubMed Strand CL, Wajsbort RR, Sturmann K. Effect of iodophor vs iodine tincture skin preparation on blood culture contamination rate. JAMA. 1993;269:1004–6.CrossRefPubMed
10.
go back to reference Weinstein MP, Mirrett S, Wilson ML, Reimer LG, Reller LB. Controlled evaluation of 5 versus 10 milliliters of blood cultured in aerobic BacT/Alert blood culture bottles. J Clin Microbiol. 1994;32:2103–6.PubMedPubMedCentral Weinstein MP, Mirrett S, Wilson ML, Reimer LG, Reller LB. Controlled evaluation of 5 versus 10 milliliters of blood cultured in aerobic BacT/Alert blood culture bottles. J Clin Microbiol. 1994;32:2103–6.PubMedPubMedCentral
11.
go back to reference Seybold U, Reichardt C, Halvosa JS, Blumberg HM. Clonal diversity in episodes with multiple coagulase-negative Staphylococcus bloodstream isolates suggesting frequent contamination. Infection. 2009;37:256–60.CrossRefPubMed Seybold U, Reichardt C, Halvosa JS, Blumberg HM. Clonal diversity in episodes with multiple coagulase-negative Staphylococcus bloodstream isolates suggesting frequent contamination. Infection. 2009;37:256–60.CrossRefPubMed
12.
go back to reference Mirrett S, Weinstein MP, Reimer LG, Wilson ML, Reller LB. Relevance of the number of positive bottles in determining clinical significance of coagulase-negative staphylococci in blood cultures. J Clin Microbiol. 2001;29:3279–81.CrossRef Mirrett S, Weinstein MP, Reimer LG, Wilson ML, Reller LB. Relevance of the number of positive bottles in determining clinical significance of coagulase-negative staphylococci in blood cultures. J Clin Microbiol. 2001;29:3279–81.CrossRef
13.
go back to reference Cross MC, Kransdorf MJ, Chivers FS, et al. Utility of percutaneous joint aspiration and synovial biopsy in identifying culture-positive infected hip arthroplasty. Skelet Radiol. 2014;43:165–8.CrossRef Cross MC, Kransdorf MJ, Chivers FS, et al. Utility of percutaneous joint aspiration and synovial biopsy in identifying culture-positive infected hip arthroplasty. Skelet Radiol. 2014;43:165–8.CrossRef
14.
go back to reference Fink B, Gebhard A, Fuerst M, Berger I, Schäfer P. High diagnostic value of synovial biopsy in periprosthetic joint infection of the hip. Clin Orthop Relat Res. 2013;471:956–64.CrossRefPubMed Fink B, Gebhard A, Fuerst M, Berger I, Schäfer P. High diagnostic value of synovial biopsy in periprosthetic joint infection of the hip. Clin Orthop Relat Res. 2013;471:956–64.CrossRefPubMed
Metadata
Title
Pathogen or contaminant? Distinguishing true infection from synovial fluid culture contamination in patients with suspected septic arthritis
Authors
Mary Louise Fowler
Clara Zhu
Kevin Byrne
Sarah B. Lieber
Andrew Moore
Robert H. Shmerling
Ziv Paz
Publication date
01-12-2017
Publisher
Springer Berlin Heidelberg
Published in
Infection / Issue 6/2017
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-017-1051-y

Other articles of this Issue 6/2017

Infection 6/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.